Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Elicio Therapeutics (ELTX) Asset Utilization Ratio (2021 - 2023)

Elicio Therapeutics posted quarterly Asset Utilization Ratio of 0.02 for Q1 2023, down 93.74% year-on-year from 0.32 in Q1 2022, and down 63.01% on a QoQ basis from 0.05 in Q4 2022.

Elicio Therapeutics (ELTX) has 3 years of Asset Utilization Ratio data on file, last reported at 0.02 in Q1 2023.

  • For the quarter ending Q1 2023, Asset Utilization Ratio fell 93.74% year-over-year to 0.02; the trailing twelve-month figure through Mar 2023 stood at 0.02 (down 93.74% YoY), and the FY2022 full-year result was 0.04, down 89.9% from the prior year.
  • Asset Utilization Ratio for Q1 2023 stood at 0.02, down from 0.05 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.42 in Q3 2022 and bottomed at 0.0 in Q2 2021.
  • The 3-year median for Asset Utilization Ratio is 0.05 (2022), against an average of 0.16.
  • The widest annual swing landed in 2022, when Asset Utilization Ratio soared 34066.99%; it then slumped 93.74% in 2023.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.27 in 2021, then tumbled by 79.43% to 0.05 in 2022, then slumped by 63.01% to 0.02 in 2023.
  • The last three Asset Utilization Ratio figures came in at 0.02 (Q1 2023), 0.05 (Q4 2022), and 0.42 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.47
7 Evaxion A 62.56 Bn 62.54 Bn - 0.29
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.85
10 Elicio Therapeutics 217.63 Mn 202.68 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 0.02
Dec 31, 2022 0.05
Sep 30, 2022 0.42
Jun 30, 2022 0.38
Mar 31, 2022 0.32
Dec 31, 2021 0.27
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00